arrow
Lv7
3608 积分
2021-08-05 加入
-
Targeting B cells for treatment of systemic sclerosis
7天前
已完结
-
Anti-DNA, antihistone, and antinucleosome antibodies in systemic lupus erythematosus and drug-induced lupus
8天前
已完结
-
Peripheral Blood B Cell Depletion after Rituximab and Complete Response in Lupus Nephritis
18天前
已完结
-
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
22天前
已完结
-
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
22天前
已完结
-
Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study
23天前
已完结
-
Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study
23天前
已完结
-
Classification and definition of major flares in SLE clinical trials
28天前
已完结
-
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
1个月前
已关闭
-
Treatment of refractory SLE with rituximab plus cyclophosphamide: clinical effects, serological changes, and predictors of response
1个月前
已完结